Fundraising Fox
🦊/People
Sign in

Zach Sweeney

Investor

Venture Partner at Versant Ventures

San Francisco Bay Area

Find your path to Zach

228 people in our graph share verified history with Zach — schools, employers, funds. One of them is your warm intro.

David SchenkeinunlockedZach: together at Denali Therapeutics (2015–2020)
×2Zach: together at Denali Therapeutics
×4Zach: together at Roche Pharmaceuticals
Zach: together at Interline Therapeutics

About

Venture Partner at Versant with extensive experience leading drug discovery across small molecule, biotherapeutic, and technology platforms. Previously co-founded and served as CEO of Interline Therapeutics, was CSO of Denali Therapeutics, and held drug discovery leadership roles at Genentech, Roche, Novartis, and Revolution Medicines. He works with entrepreneurs to build new companies from early-stage science.

Experience

  1. Versant VenturesVenture Partnercurrent2024 — present
  2. Interline TherapeuticsCEO2020 — 2024San Francisco Bay Area
  3. Denali TherapeuticsChief Scientific Officer and Head of Discovery2015 — 2020
  4. REVOLUTION MedicinesSenior Director of Chemistry2015
  5. Novartis Institutes for BioMedical ResearchDirector of Medicinal and Analytical Chemistry2011 — 2015San Francisco Bay Area
  6. GenentechProject Leader2009 — 2011
  7. Roche PharmaceuticalsPrincipal Research Scientist2002 — 2008Roche Palo Alto

Skills & more

Drug Discovery27Medicinal Chemistry25Drug Development6Organic Synthesis7Biotechnology11Life Sciences14Organic Chemistry6Drug Design32HPLC2Analytical Chemistry2Biochemistry4Chemistry6
+2 moreChromatographyPharmaceutical Industry

From Zach's professional profile.

Colleagues at Versant Ventures

Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Venture Advisor at Intuitive Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures
Brian Atwood
Managing Director at Versant Ventures

Frequently asked questions

Who is Zach Sweeney?
Venture Partner at Versant with extensive experience leading drug discovery across small molecule, biotherapeutic, and technology platforms. Previously co-founded and served as CEO of Interline Therapeutics, was CSO of Denali Therapeutics, and held drug discovery leadership roles at Genentech, Roche, Novartis, and Revolution Medicines. He works with entrepreneurs to build new companies from early-stage science.
Where does Zach Sweeney work?
Zach Sweeney is Venture Partner at Versant Ventures.
Where did Zach Sweeney go to school?
Zach Sweeney studied at Harvard University (NIH Postdoctoral Fellowship, Chemistry); University of California, Berkeley (PhD, Chemistry); Stanford University (BS, Chemistry).

Same school

Shared employers

Also worked at Interline Therapeutics1

Jay ParrishVenture Partner at ARCH Venture Partners